Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2003;3(4):299. doi: 10.1385/CT:3:4:299

Increase in cardiovascular pathology in female sprague-dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3′,4,4′,5-pentachlorobiphenyl

Micheal P Jokinen 1, Nigel J Walker 2, Amy E Brix 3, Donald M Sells 4, Joseph K Haseman 5, Abraham Nyska 6,✉
PMCID: PMC7090859  PMID: 14734827

Abstract

The effects of chronic exposure to dioxin (2,3,7,8,-tetrachlorodibenzo-p-dioxin [TCDD]) and a dioxin-like compound (3,3′,4,4′,5-pentachlorobiphenyl [PCB126]) on the cardiovascular system were evaluated in female Harlan Sprague-Dawley rats as part of an ongoing National Toxicology Program investigation. The animals were gavage treated 5 d per week with up to 1000 ng of PCB126 per kilogram of body weight per day or up to 100 ng of TCDD per kilogram of body weight per day for up to 2 yr. The control animals received only a corn oil/acetone vehicle (99:1 mixture). The corresponding stop-study groups received the highest doses for 31 wk and then received only the vehicle for the remainder of the study. After a full necropsy of all animals, a complete set of tissues was examined microscopically. Administration of each compound was associated with treatment-related increases in the incidences of degenerative cardiovascular lesions. Cardiomyopathy and chronic active arteritis increased in a dose-related manner in all groups treated with PCB126 or with TCDD. Increased incidences were also observed in the stop-study groups, indicating that a shorter term exposure may produce some effects. The average severity of cardiomyopathy was minimal or slightly greater in all dose groups, including the controls. Chronic active arteritis occurred primarily in the mesentery and pancreas, although the rectum, liver, heart, ovary, uterus, and glandular stomach in the PCB126 study and the liver and ovary in the TCDD study were affected in a few of the dosed animals. The authors’ investigations indicate that the rat cardiovascular system is a target for dioxin toxicity, which increases the incidence of spontaneous cardiomyopathy and arteritis.

Key Words: Dioxin, heart, cardiomyopathy, artery, vasculitis, polychlorinated biphenyls

References

  • 1.Calvert G.M., Wall D.K., Sweeney M.H., Fingerhut M.A. Evaluation of cardiovascular outcomes among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ. Health Perspect. 1998;106:S635–S643. doi: 10.2307/3433814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Flesch-Janys D., Berger J., Gurn P., Manz A., Nagel S., Waltsgott H., et al. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am. J. Epidemiol. 1995;142:1165–1175. doi: 10.1093/oxfordjournals.aje.a117575. [DOI] [PubMed] [Google Scholar]
  • 3.Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 1978;46:279–303. doi: 10.1016/0041-008X(78)90075-3. [DOI] [PubMed] [Google Scholar]
  • 4.Brewster D.W., Bombick D.W., Matsumura F. Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) J. Toxicol. Environ. Health. 1988;25:495–507. doi: 10.1080/15287398809531227. [DOI] [PubMed] [Google Scholar]
  • 5.Dalton T.P., Kerzee J.K., Wang B., Miller M., Dieter M.Z., Lorenz J.N., et al. Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc. Toxicol. 2001;1:285–298. doi: 10.1385/CT:1:4:285. [DOI] [PubMed] [Google Scholar]
  • 6.Riecke K., Grimm D., Shakibaei M., Kossmehl P., Schulze-Tanzil G., Paul M., et al. Low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets (Callithrixjacchus) Arch. Toxicol. 2002;76:360–366. doi: 10.1007/s00204-002-0338-6. [DOI] [PubMed] [Google Scholar]
  • 7.Dong W., Teraoka H., Yamazaki K., Tsukiyama S., Imani S., Imagawa T., et al. 2,3,7,8-Tetrachloro-dibenzo-p-dioxin toxicity in the zebrafish embryo: local circulation failure in the dorsal midbrain is associated with increased apoptosis. Toxicol. Sci. 2002;69:191–201. doi: 10.1093/toxsci/69.1.191. [DOI] [PubMed] [Google Scholar]
  • 8.Ivnitski I., Elmaoued R., Walker M.K. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis. Teratology. 2001;64:201–212. doi: 10.1002/tera.1065. [DOI] [PubMed] [Google Scholar]
  • 9.Heid S.E., Walker M.K., Swanson H.I. Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci. 2001;61:187–196. doi: 10.1093/toxsci/61.1.187. [DOI] [PubMed] [Google Scholar]
  • 10.Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 1996;140:173–179. doi: 10.1006/taap.1996.0210. [DOI] [PubMed] [Google Scholar]
  • 11.Walker N.J., Tritscher A.M., Sills R.C., Lucier G.W., Portier C.J. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2000;54:330–337. doi: 10.1093/toxsci/54.2.330. [DOI] [PubMed] [Google Scholar]
  • 12.Van den Berg M., Birnbaum L., Bosveld A.T.C., Brunstrom B., Cook P., Feeley M., et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 1998;106:775–792. doi: 10.2307/3434121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Grossblatt N. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996. [Google Scholar]
  • 14.Bailey A.J., Portier C.J. Effect of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics. 1988;44:417–431. doi: 10.2307/2531856. [DOI] [PubMed] [Google Scholar]
  • 15.Portier C.J., Bailer A.J. Testing for increased carcinogenicity using a survival-adjusted quantal response. test. Fundam. Appl. Toxicol. 1989;12:731–737. doi: 10.1016/0272-0590(89)90004-3. [DOI] [PubMed] [Google Scholar]
  • 16.MacKenzie W.F., Alison R.H. Heart. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery C.A. Jr., MacKenzie W.F., editors. Pathology of the Fischer Rat. San Diego, CA: Academic Press; 1990. pp. 461–471. [Google Scholar]
  • 17.Greaves P. Cardiovascular system. In: Greaves P., editor. Histopathology of Preclinical Toxicity Studies. Amsterdam: Elsvier; 2000. pp. 254–311. [Google Scholar]
  • 18.Rao G.N., Morris R.W., Seely J.C. Beneficial effects of NTP-2000 diet on growth, survival, and kidney and heart diseases of Fischer 344 rats in chronic studies. Toxicol. Sci. 2001;63:245–255. doi: 10.1093/toxsci/63.2.245. [DOI] [PubMed] [Google Scholar]
  • 19.Kemi M., Keenan K.P., McCoy C., Hoe C.M., Soper K.A., Ballam G.C., et al. The relative protective effects of moderate dietary restriction versus dietary modification on spontaneous cardiomyopathy in male Sprague-Dawley rats. Toxicol. Pathol. 2000;28:285–296. doi: 10.1177/019262330002800208. [DOI] [PubMed] [Google Scholar]
  • 20.Lewis D.H. Nonneoplastic lesions in the cardiovascular system. In: Mohr U., Dungworth D.L., Capen C.C., editors. Pathobiology of the Aging Rat. Washington, DC: ILSI Press; 1993. pp. 301–309. [Google Scholar]
  • 21.Ruben Z., Arceo R.J., Bishop S.P., Elwell M.R., Kern W.D., Mesfin G.M., et al. Guides for Toxicologic Pathology. Washington, DC: STP/ARP/AFIP; 2000. Non-proliferative lesions of the heart and vasculature in rats. [Google Scholar]
  • 22.Canga L., Paroli L., Blanck T.J., Silver R.B., Rifkind A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol. Pharmacol. 1993;44:1142–1151. [PubMed] [Google Scholar]
  • 23.Xie A., Walker N.J., Wang D. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on triggered-after-depolarizations in isolated rat ventricular myocytes. The Toxicologist. 2003;72:1–1. [Google Scholar]
  • 24.Walker M.K., Johnson C.D., Tadesse M., Ramos K.S., Steele L.D., Thackaberry E.A. Dioxin induces growth arrest and reduces cell cycle gene expression in the fetal murine heart. The Toxicologist. 2003;72:231–231. [Google Scholar]
  • 25.Mitsumori K. Blood and lymphatic vessels. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery C.A. Jr., MacKenzie W.F., editors. Pathology of the Fischer Rat. San Diego, CA: Academic Press; 1990. pp. 473–484. [Google Scholar]
  • 26.Nyska A., Herbert R.A., Chan P.C., Haseman J.K., Hailey J.R. Theophylline-induced mesenteric periarteritis in F344/N rats. Arch. Toxicol. 1998;72:731–737. doi: 10.1007/s002040050567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Joseph E.C., Rees J.A., Dayan A.D. Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: an investigation of morphological, ultrastructural, and hemodynamic changes. Toxicol. Pathol. 1996;24:436–450. doi: 10.1177/019262339602400406. [DOI] [PubMed] [Google Scholar]
  • 28.Johansson S. Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. Acta Pathol. Microbiol. Scand. [A] 1981;89:185–191. doi: 10.1111/j.1699-0463.1981.tb00207.x. [DOI] [PubMed] [Google Scholar]
  • 29.Kerns W.D., Joseph E.C., Morgan E.D. Drug-induced lesions, arteries, rat. In: Jones T.C., Mohr U., Hunt R.C., editors. Cardiovascular and Musculoskeletal Systems. Berlin: Springer Verlag; 1991. pp. 76–83. [Google Scholar]
  • 30.Kerns W.A. Pathogenesis of drug-induced myocardial and arterial lesions: current concepts. Vet. Pathol. 1996;33:574–574. [Google Scholar]
  • 31.Kerns W.D., Arena E., Macia R.A., Bugelski P.J., Matthews W.D., Morgan D.G. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat. Toxicol. Pathol. 1989;17:203–213. doi: 10.1177/019262338901700116. [DOI] [PubMed] [Google Scholar]
  • 32.Schoen F.J. The heart. In: Cotran R.S., Kumar V., Robbins S.L., editors. Robbins Pathologic Basis of Disease. Philadelphia: W.B. Saunders; 1994. pp. 517–582. [Google Scholar]
  • 33.Schoen F.J. Blood vessels. In: Cotran R.S., Kumar V., Robbins S.L., editors. Robbins Pathologic Basis of Disease. Philadelphia: W.B. Saunders; 1994. pp. 467–516. [Google Scholar]

Articles from Cardiovascular Toxicology are provided here courtesy of Nature Publishing Group

RESOURCES